Vol 91, No 7 (2020)
Research paper
Published online: 2020-06-16

open access

Page views 1339
Article views/downloads 1315
Get Citation

Connect on Social Media

Connect on Social Media

Should the patients with endometriosis be treated as a risk group of pregnancy complications? Single center experience and literature review and literature review

Damian Warzecha1, Bronislawa Pietrzak1, Iwona Szymusik1, Zuzanna Smiech2, Miroslaw Wielgos1
Pubmed: 32542643
Ginekol Pol 2020;91(7):383-388.


Objectives: Multidirectional influence of endometriosis on fertility impairments is well known. Altered implantation and placentation among affected patients raised concerns regarding possible negative influence on the course of pregnancy. The primary objective of the study was to assess the course of gestation and the incidence of pregnancy complications among women with endometriosis. It also aimed to determine whether the method of conception might impact the primary results. Material and methods: A single-center cohort study included 64 women with confirmed endometriosis and 296 healthy controls. Data concerning treatment of endometriosis related infertility, course of pregnancy and perinatal outcomes were evaluated. Results: Patients with endometriosis were older than controls (33.6 +/- 4.2 y vs 31.8 +/- 4.6, p = 0.01) and more often gave birth for the first time (87.5% vs 43.9%, p = 0.001). The age at the time of first delivery was significantly higher within the study group (33.1 y +/- 4.1 vs 29.9 +/- 4.6, p < 0.001). In the study, 81.2% of patients with endometriosis had the diagnosis of infertility. Patients suffering from endometriosis were significantly more prone to spontaneous placental abruption during pregnancy and delivery (4.7 vs 0.3%, odds ratio = 14.5). Several complications occurred more often in endometriotic patients (gestational diabetes mellitus, small-for-gestational-age and anemia); however, without statistical significance. The risk of pregnancy complications was independent from stage of endometriosis and way of conception. The incidences of adverse neonatal outcomes (preterm delivery, low Apgar score, lower birth weight) were similar in both groups. Conclusions: Endometriosis may adversely affect perinatal outcomes, especially due to increased risk of placenta abruption and operative delivery. Stage of endometriosis and method of conception does not enhance these complications.

Article available in PDF format

View PDF Download PDF file


  1. Stilley JAW, Birt JA, Sharpe-Timms KL. Cellular and molecular basis for endometriosis-associated infertility. Cell Tissue Res. 2012; 349(3): 849–862.
  2. Mishra V. Prevalence; Characteristics and Management of Endometriosis Amongst Infertile Women: A One Year Retrospective Study. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. 2015.
  3. Morassutto C, Monasta L, Ricci G, et al. Incidence and Estimated Prevalence of Endometriosis and Adenomyosis in Northeast Italy: A Data Linkage Study. PLOS ONE. 2016; 11(4): e0154227.
  4. Kitawaki J, Noguchi T, Amatsu T, et al. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol Reprod. 1997; 57(3): 514–519.
  5. Fox C, Morin S, Jeong JW, et al. Local and systemic factors and implantation: what is the evidence? Fertil Steril. 2016; 105(4): 873–884.
  6. Kim BG, Yoo JY, Kim TH, et al. Aberrant activation of signal transducer and activator of transcription-3 (STAT3) signaling in endometriosis. Hum Reprod. 2015; 30(5): 1069–1078.
  7. Sharkey AM, Macklon NS. The science of implantation emerges blinking into the light. Reprod Biomed Online. 2013; 27(5): 453–460.
  8. Lessey BA, Kim JJ. Endometrial receptivity in the eutopic endometrium of women with endometriosis: it is affected, and let me show you why. Fertil Steril. 2017; 108(1): 19–27.
  9. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997; 67(5): 817–821.
  10. ACOG Practice Bulletin No. 204 Summary: Fetal Growth Restriction. Obstet Gynecol. 2019; 133(2): 390–392.
  11. Domanski G, Lange AE, Ittermann T, et al. Evaluation of neonatal and maternal morbidity in mothers with gestational diabetes: a population-based study. BMC Pregnancy Childbirth. 2018; 18(1): 367.
  12. Gibson C, Rohan AM, Gillespie KH. Severe Maternal Morbidity During Delivery Hospitalizations. WMJ. 2017; 116(5): 215–220.
  13. Harada T, Taniguchi F, Onishi K, et al. Japan Environment & Children’s Study Group. Obstetrical Complications in Women with Endometriosis: A Cohort Study in Japan. PLoS One. 2016; 11(12): e0168476.
  14. Hadfield RM, Lain SJ, Raynes-Greenow CH, et al. Is there an association between endometriosis and the risk of pre-eclampsia? A population based study. Hum Reprod. 2009; 24(9): 2348–2352.
  15. Berlac JF, Hartwell D, Skovlund CW, et al. Endometriosis increases the risk of obstetrical and neonatal complications. Acta Obstet Gynecol Scand. 2017; 96(6): 751–760.
  16. Glavind MT, Forman A, Arendt LH, et al. Endometriosis and pregnancy complications: a Danish cohort study. Fertil Steril. 2017; 107(1): 160–166.
  17. Farland LV, Prescott J, Sasamoto N, et al. Endometriosis and Risk of Adverse Pregnancy Outcomes. Obstet Gynecol. 2019; 134(3): 527–536.
  18. Tobias DK, Chavarro JE, Williams MA, et al. History of infertility and risk of gestational diabetes mellitus: a prospective analysis of 40,773 pregnancies. Am J Epidemiol. 2013; 178(8): 1219–1225.
  19. Pérez-López FR, Martínez-Domínguez SJ, Viñas A, et al. Health Outcomes and Systematic Analyses (HOUSSAY) Project. Endometriosis and gestational diabetes mellitus risk: a systematic review and meta-analysis. Gynecol Endocrinol. 2018; 34(5): 363–369.
  20. Takemura Y, Osuga Y, Fujimoto A, et al. Increased risk of placenta previa is associated with endometriosis and tubal factor infertility in assisted reproductive technology pregnancy. Gynecol Endocrinol. 2013; 29(2): 113–115.
  21. Porpora MG, Tomao F, Ticino A, et al. Endometriosis and Pregnancy: A Single Institution Experience. Int J Environ Res Public Health. 2020; 17(2).
  22. Horton J, Sterrenburg M, Lane S, et al. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis. Hum Reprod Update. 2019; 25(5): 592–632.
  23. Bulletti C, Montini A, Setti PL, et al. Vaginal parturition decreases recurrence of endometriosis. Fertil Steril. 2010; 94(3): 850–855.
  24. Allerstorfer C, Oppelt P, Enzelsberger SH, et al. Delivery after Operation for Deeply Infiltrating Endometriosis. Biomed Res Int. 2016; 2016: 8271452.
  25. Saraswat L, Ayansina DT, Cooper KG, et al. Pregnancy outcomes in women with endometriosis: a national record linkage study. BJOG. 2017; 124(3): 444–452.
  26. Vander Borght M, Wyns C. Fertility and infertility: Definition and epidemiology. Clin Biochem. 2018; 62: 2–10.
  27. Harb HM, Gallos ID, Chu J, et al. The effect of endometriosis on in vitro fertilisation outcome: a systematic review and meta-analysis. BJOG. 2013; 120(11): 1308–1320.
  28. Dunselman GAJ, Vermeulen N, Becker C, et al. European Society of Human Reproduction and Embryology. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014; 29(3): 400–412.
  29. Ballard KD, Seaman HE, de Vries CS, et al. Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study--Part 1. BJOG. 2008; 115(11): 1382–1391.
  30. Hudelist G, Fritzer N, Thomas A, et al. Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences. Hum Reprod. 2012; 27(12): 3412–3416.
  31. Soliman AM, Fuldeore M, Snabes MC. Factors Associated with Time to Endometriosis Diagnosis in the United States. J Womens Health (Larchmt). 2017; 26(7): 788–797.
  32. Daniilidis A, Pados G. Comments on the ESHRE recommendations for the treatment of minimal endometriosis in infertile women. Reprod Biomed Online. 2018; 36(1): 84–87.